Introduction
============

Myopia is the most common cause of vision impairment worldwide, with a prevalence of approximately 25.4%--80% \[[@r1]--[@r3]\]. The prevalence of myopia reaches 71%--96% in students living in the developed region of East Asia \[[@r4],[@r5]\] and is expected to increase \[[@r6]--[@r8]\]. Both environmental and genetic factors are believed to play important roles in the development of myopia, but the exact molecular basis of this condition is still unknown \[[@r1],[@r9]\].

Molecular genetic studies have identified several loci associated with a predisposition to myopia \[[@r10]--[@r27]\]. However, the genes at most of these loci remain to be identified \[[@r28],[@r29]\]. In the past three years, several independent genome-wide association studies (GWAS) have focused on the search for genetic factors contributing to myopia \[[@r20],[@r30]--[@r34]\]. Two of these studies were based on Japanese populations, and identified several single nucleotide polymorphisms (SNPs) significantly associated with high myopia, including [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948) and [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544) at chromosome 11q24.1 and [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471) at chromosome 21q22.3 \[[@r20],[@r30]\]. Replication is an important step to confirm the original findings of association studies; although the original reports suggested replication studies to validate their findings, these have yet to be performed.

Both Chinese and Japanese populations exhibit a very high prevalence of myopia. Additionally, the populations of these two regions are closely related \[[@r35]\]. The LD structures around [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948), [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544), and [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471) are very similar between Chinese and Japanese populations according to data from [HapMap Phase 3](http://hapmap.ncbi.nlm.nih.gov/). Therefore, we performed a replication study to examine whether the SNPs [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948), [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544), and [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471) are also associated with myopia in Chinese individuals.

Methods
=======

Subjects
--------

A total of 2,870 unrelated individuals were examined in this study, including 1,052 healthy controls and 1,818 myopia cases. Based on degrees of spherical refraction, the 1,818 subjects with myopia were classified into three groups: −6.00 diopter (D)\<spherical refraction≤-4.00 D for 423 cases, −9.25 D\<spherical refraction≤-6.00 D for 1,124 cases, and spherical refraction≤-9.25 D (−9.25 D was the criterion for myopia used in the original study \[[@r20]\]) for 271 cases. The 1,818 myopia cases were divided into two groups based on genetic contribution: 563 cases with early onset high myopia and 1,255 cases with complex myopia. The 563 individuals with early onset high myopia were identified at the Pediatric and Genetic Clinic of the Zhongshan Ophthalmic Center. The enrollment criteria used were basically the same as previously described \[[@r15]\]: 1) myopia was present before attending primary school; 2) spherical refraction ≤-6.00 D; 3) no other known ocular or systemic diseases. The 1,255 subjects with complex myopia and 1,052 healthy controls were college students recruited from 12 universities in Guangzhou. The 1,255 subjects with myopia met the following criteria: 1) spherical refraction at each meridian ≤-4.00 D; 2) best corrected visual acuity (BCVA) ≤0.1 in logMAR; 3) myopia onset occurred after 7 years of age; 4) no other known eye or related systemic diseases were present; 5) no family history of high myopia existed. The 1,052 subjects in the healthy control group met the following criteria: 1) bilateral refraction measured between −0.50 D and +2.00 D (spherical equivalent); 2) best unaided visual acuity ≤0 in logMAR; 3) no other known eye or related systemic diseases were present; 4) no family history of high myopia was documented.

The results of ophthalmologic examinations were recorded, including visual acuity (unaided, near, and/or best), color vision, slit lamp and direct ophthalmoscope examination. Refractive errors were measured using an autorefractor (Topcon KR-8000, Paramus, NJ) after mydriasis with compound tropicamide (Mydrin®-P, Santen Pharmaceutical Co. Ltd., Osaka, Japan). All of the college students recruited from 12 universities in Guangzhou received an ocular biometry examination using IOL master V5 (Carl Zeiss Meditec AG, Jena, Germany). Additional examinations included an electroretinogram and fundus photograph in selected individuals. The study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Zhongshan Ophthalmic Center, Guangzhou China. As this study was part of a project with the aim of identifying genetic factors related to myopia, the procedure for obtaining informed consent and collecting subjects was the same as previously described \[[@r36]\]. Genomic DNA was prepared from venous blood samples obtained from the study subjects.

Genotyping
----------

Restriction fragment length polymorphism (RFLP) analysis was used to detect the SNP [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471). The primers that were used to amplify the DNA fragment that included [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471) \[provided by the National Center for Biotechnology Information ([NCBI](http://www.ncbi.nlm.nih.gov/snp/))\] are listed in [Table 1](#t1){ref-type="table"}. The amplicon was digested using the restriction endonuclease Hpy188I according to the manufacturer's instructions (New England Biolabs \[Beijing\], Ltd, Beijing, China\]. The digested products were analyzed by PAGE.

###### Primers used for genotyping

  **SNP**                                                                          **Direction**   **Primer sequence (5′-3′)**
  -------------------------------------------------------------------------------- --------------- ------------------------------------------------
  [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471)     F               TGGGGCTGCAGGTGTTGTG
                                                                                   R               AGTGGGCCAGCTAGGAAAAGAAA
  [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948)       Nest-F          CACAATGCAAAGGATCAGAGC
                                                                                   Nest-R          AGCGTGATCAGAATACAAGATGG
                                                                                   F-A             ACTGTCAGAAACTCAACTCTCA
                                                                                   F-G             TATAACTGTCAGAAACTCAACTCTCG
                                                                                   R-Pub+M13       CGTTGTAAAACGACGGCCAGTatcagaatacaagatggagcgtagg
  [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544)   Nest-F          GCAAAGGAAACAATCAACAGAG
                                                                                   Nest-R          AAAGGTGTCCAAATGATAGCC
                                                                                   F-T             CAAATCACTAACCTTTCCAGAACAT
                                                                                   F-G             TATACAAATCACTAACCTTTCCAGAACAG
                                                                                   R-Pub+M13       CGTTGTAAAACGACGGCCAGTggaccaaagacagctcaaacc
  M13 probe                                                                                        FAM-CGTTGTAAAACGACGGCCAGT

The SNPs [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948) and [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544) were genotyped by nested polymerase chain reaction (nest-PCR) combined with fluorescence-labeled allele-specific PCR (AS-PCR). Briefly, two pairs of primers were used. The first pair of primers was designed to amplify fragments encompassing the SNPs. The amplicons were then used as templates for a second round of PCR, in which three internal primers and a labeled common primer were used: two SNP allele-specific primers with a length difference of 4 bp, a reverse specific primer with an M13 tail, and a 5′-FAM-labeled M13 probe ([Table 1](#t1){ref-type="table"}). Finally, the labeled allele-specific amplicons were analyzed using capillary electrophoresis in an ABI 3100 genetic analyzer (Applied Biosystems, Foster City, CA) and analyzed using GeneMapper software v3.5 (Applied Biosystems).

For each SNP, 48 samples were simultaneously analyzed by cycle sequencing to ensure that either the RFLP or M13-tailed method was reliable. Genotyping results were read independently by two researchers. Two types of additional validation were conducted: 1) direct sequencing of the first round of PCR products from four samples in each plate (96 samples); and 2) any sample that was read differently by the two researchers was confirmed by sequencing.

Statistical analysis
--------------------

The distribution of sexes was compared between the myopia cases and healthy controls with a χ^2^ test. The average age was compared between the myopia cases and healthy controls with a *t*-test. The distribution of all three SNPs was evaluated with respect to Hardy--Weinberg equilibrium (HWE). The frequencies of alleles and genotypes in the early onset high myopia and complex myopia groups, as well as in the classified spherical refraction groups were compared with those in the healthy control group using a χ^2^ test. A p\<0.05 was used as the level of statistical significance (α), and a Bonferroni correction was applied for multiple testing, correcting the threshold for significance from 0.05 to 0.017 (α/3=0.05/3).

Results
=======

The basic clinical information for all 2870 subjects is listed in [Table 2](#t2){ref-type="table"}. Genotyping of [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471), [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948), and [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544) was successfully performed in the 2,870 unrelated subjects ([Figure 1](#f1){ref-type="fig"}, [Table 3](#t3){ref-type="table"}, and [Table 4](#t4){ref-type="table"}). The genotyping success rate was 100% for the three SNPs. There was no significant deviation from HWE for any of the three SNPs in the healthy controls. No statistically significant difference in genotype frequencies or allele frequencies was found between the myopia cases and controls, regardless of whether myopia was classified into early onset high myopia and complex myopia or classified into three groups based on spherical refraction ([Table 3](#t3){ref-type="table"} and [Table 4](#t4){ref-type="table"}). Although the frequency of [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544) exhibited a slight difference between the complex myopia group and healthy control group (allele p=0.032), the difference was not significant after Bonferroni correction with a corrected significance level of p=0.017.

###### Basic information for the 2,870 subjects.

  **Category**         **Early onset high myopia**   **Complex myopia**       **Healthy control**                                                                     
  -------------------- ----------------------------- ------------------------ --------------------- ------------------------ ------------------------ --------------- ------------------------
                                                     **−9.25 D\<S≤-6.00 D**   **S≤-9.25 D**         **−6.00 D\<S≤-4.00 D**   **−9.25 D\<S≤-6.00 D**   **S≤-9.25 D**   **−0.50 D≤SE≤+2.00 D**
  Number of subjects   355                           208                      615                   610                      30                       1052            
  Age (years)          Range                         0.3\~79                  2\~64                 16\~27                   15\~33                   19\~27          16\~32
                       Average                       13.44±9.28               20.06±14.01           20.70±1.59               20.85±1.73               20.94±1.53      20.91±1.78
  Gender               Male                          0.535                    0.474                 0.503                    0.476                    0.486           0.597
                       Female                        0.465                    0.526                 0.497                    0.524                    0.514           0.403
  Refraction (D)       Range                         −6.00\~-9.00             −30.00\~-9.25         −4.00D\~-5.87D           −6.00D\~-9.00D           −10.00\~-9.25   −0.5\~+2.00
                       Average                       −7.70±0.95               −14.46±4.51           −5.06±0.52               −7.00±0.88               −9.64±0.31      0.25±0.52
  Axial length (mm)    Range                         not available            not available         23.39\~28.36             24.00\~29.30             25.29\~29.32    20.30\~26.53
                       Average                                                                      25.79±0.81               26.48±0.91               27.29±0.83      23.60±0.79

Abbreviations: S,spherical refraction; SE,spherical equivalent.

![Genotyping of [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471), [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948), and [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544). The three SNPs were successfully genotyped in 2,870 subjects. M: 100 bp DNA ladder. **A**: RFLP analysis of SNP [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471). The double bands at 337 bp and 298 bp represent genotype C/T, the single band at 298 bp represents C/C, and the single band at 337 bp represents T/T. Capillary electrophoresis analysis was used for genotyping [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948) and [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544). The three peak patterns represent three different SNP genotypes. **B**: SNP [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948): the single peak at 181 bp is genotype A/A, the double peaks at 181 bp and 185 bp are A/G, and the single peak at 185 bp is G/G. **C**: SNP rs11218544: the single peak at 201 bp is T/T, the double peaks at 201 bp and 205 bp are T/G, and the single peak at 205 bp is G/G.](mv-v17-3290-f1){#f1}

###### Allele frequency and genotypes of the three SNPs in myopia cases and healthy controls. Myopia was classified as early onset high myopia and complex myopia.

  **SNPs**                                                                         **Allele (A/B)**   **Classification of subjects**   **Number of subjects**       **MAF**   **Genotype**   **p value\***   **OR**    **95%CI**                                       
  -------------------------------------------------------------------------------- ------------------ -------------------------------- ---------------------------- --------- -------------- --------------- --------- ----------- ------------ -------------- ------- --------------
                                                                                                                                                                                             **A/A**         **A/B**   **B/B**     **Allele**   **Genotype**            
  [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471)     C/T                myopia                           complex (−10.00D≤S≤-4.00D)   1255      0.489          293             641       321         0.393        0.266          1.052   0.937--1.181
                                                                                                                                       early onset (S≤-6.00D)       563       0.472          116             300       147         0.838        0.131          0.985   0.852--1.139
                                                                                                                                       complex+early onset          1818      0.484          409             941       468         0.582        0.151          1.031   0.926--1.148
                                                                                                      healthy control                  −0.50D≤SE≤+2.00D             1052      0.476          248             506       298                                              
  [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948)       A/G                myopia                           complex (−10.00D≤S≤-4.00D)   1255      0.494          302             665       288         0.307        0.269          1.062   0.946--1.193
                                                                                                                                       early onset (S≤-6.00D)       563       0.491          123             307       133         0.973        0.282          1.003   0.867--1.159
                                                                                                                                       complex+early onset          1818      0.499          425             972       421         0.439        0.207          1.043   0.937--1.162
                                                                                                      healthy control                  −0.50D≤SE≤+2.00D             1052      0.49           251             530       271                                              
  [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544)   G/T                myopia                           complex (−10.00D≤S≤-4.00D)   1255      0.401          200             607       448         0.032        0.098          1.14    1.012--1.284
                                                                                                                                       early onset (S≤-6.00D)       563       0.382          83              264       216         0.515        0.771          1.051   0.905--1.220
                                                                                                                                       complex+early onset          1818      0.395          283             871       664         0.061        0.17           1.112   0.995--1.242
                                                                                                      healthy control                  −0.50D≤SE≤+2.00D             1052      0.37           142             495       415                                              

Note: MAF=minor allele frequency; S=spherical refraction; SE=spherical equivalent. \*P value was calculated by chi-square test between myopia and normal control.

###### Allele frequency and genotypes of the three SNPs in myopia cases and healthy controls. Myopia was classified based on the degrees of refractive errors.

  **SNPs**                                                                         **Allele (A/B)**   **Classification of subjects**   **Number of subjects**   **MAF**   **Genotype**   **p value\***   **OR**   **95%CI**                               
  -------------------------------------------------------------------------------- ------------------ -------------------------------- ------------------------ --------- -------------- --------------- -------- ----------- -------- ---------- ------- --------------
                                                                                                                                                                                         A/A             A/B      B/B         Allele   Genotype            
  [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471)     C/T                myopia                           −6.00D\<S≤-4.00D         615       0.497          153             313      149         0.132    0.19       1.114   0.968\~1.283
                                                                                                                                       −9.25D\<S≤-6.00D         965       0.478          212             499      254         0.899    0.269      1.008   0.891\~1.141
                                                                                                                                       S≤-9.25D                 238       0.456          44              129      65          0.422    0.153      0.921   0.755\~1.125
                                                                                                      Healthy control                  −0.50D≤SE≤+2.00D         1052      0.476          248             506      298                                      
  [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948)       A/G                myopia                           −6.00D\<S≤-4.00D         615       0.497          152             315      148         0.477    0.735      1.052   0.914--1.211
                                                                                                                                       −9.25D\<S≤-6.00D         965       0.499          216             531      218         0.591    0.099      1.034   0.914--1.171
                                                                                                                                       S≤-9.25D                 238       0.496          57              126      55          0.589    0.673      1.056   0.866--1.289
                                                                                                      Healthy control                  −0.50D≤SE≤+2.00D         1052      0.49           251             530      271                                      
  [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544)   G/T                myopia                           −6.00D\<S≤-4.00D         615       0.402          103             289      223         0.065    0.148      1.146   0.992--1.323
                                                                                                                                       −9.25D\<S≤-6.00D         965       0.397          153             460      352         0.082    0.21       1.119   0.986--1.271
                                                                                                                                       S≤-9.25D                 238       0.37           27              122      89          0.984    0.446      0.998   0.812--1.226
                                                                                                      Healthy control                  −0.50D≤SE≤+2.00D         1052      0.37           142             495      415                                      

Note: MAF=minor allele frequency; S=spherical refraction; SE=spherical equivalent. \*P value was calculated by χ^2^ test between myopia and normal control.

Discussion
==========

In this study, we genotyped three SNPs that were previously reported to be significantly associated with myopia. The SNP [rs2839471](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2839471) is located in the region of the uromodulin-like 1 (*UMODL1*) gene, which may be associated with extracellular matrix and involved in the formation of sclera \[[@r37],[@r38]\]. The SNPs [rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948) and [rs11218544](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=11218544) are located in a region that includes two genes, BH3-like motif containing protein (*BLID*) and *LOC39959*. *BLID* is expressed in mitochondria, and may function in apoptosis in pathological myopia \[[@r39]--[@r41]\]. *LOC399959* is a hypothetical noncoding RNA \[[@r30]\]. Further study may elaborate the function of these genes. In the previous Japanese studies, axial length or spherical equivalent were used as criteria for recruiting the myopia patients. The proportion of early onset myopia or complex myopia was not reported \[[@r20],[@r30]\]. In this study, no significant association was found between myopia and the three SNPs examined, regardless of whether myopia was classified based on genetic contribution (early onset high myopia and complex myopia) or based on degrees of spherical refraction. Therefore, our results suggest that these three SNPs may not be associated with myopia in the Chinese subjects we studied. Currently, multiple association studies are inconsistent and the causes of these contradictions have been widely analyzed \[[@r42],[@r43]\]. The reasons why our results in the Chinese population were not identical to the Japanese results are likely related to the recruitment criteria, environmental influences, and genetic differences between the Chinese population and Japanese population because an earlier Chinese replication of a Japanese study on chromosome 11q24.1 ([rs577948](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=577948)) also failed to confirm the reported association \[[@r44]\]. Furthermore, another explanation may be that the genetic variants interact with one another, and the interaction between genes and environmental factors vary in different human populations, although this has not been systematically assessed \[[@r45]\]. Although our results do not support the previous findings related to these SNPs \[[@r20],[@r30]\], the results obtained with a Japanese population cannot be considered false-positives at this stage. However, this result must be analyzed with great caution until additional replication studies confirm a reported association, especially for myopia.

The distribution of sexes was not completely matched in the myopia and healthy control groups. However, this does not affect our conclusions because the results were unaffected when male subjects were randomly excluded to reach a balanced proportion of sexes. In addition, on average our study subjects were younger than those in the Japanese study for both cases and controls. This should not influence our conclusion because myopia is an early onset disease, and the degree of refractive error in myopia usually increases with age \[[@r46]--[@r48]\]. In our study females are more myopic (odds ratio\>1, p\<0.05) than males, which is consistent with previous reports \[[@r49],[@r50]\]. On the other hand, males with a higher prevalence of myopia or no difference among genders were also reported \[[@r45],[@r51],[@r52]\]. Lower age as a predictor of myopia (odds ratio\<1,p\<0.001) was also consistent with results reported in other populations \[[@r53],[@r54]\].

Myopia is a genetically heterogeneous disease, and both early onset and complex traits have been suggested to be associated with myopia. Traditionally, myopia has generally been classified based on degrees of spherical refraction or their closely related axial length \[[@r20],[@r30]\]. In this study, we attempted to classify myopia based on either the type of genetic contribution, or based on degrees of spherical refraction. We did not find a significant association between the SNPs analyzed and myopia in either case. Additional studies are expected to validate the original findings \[[@r20],[@r30]\].
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